110 related articles for article (PubMed ID: 6378362)
1. Endotoxin-induced antitumor activity in the mouse is highly potentiated by muramyl dipeptide.
Bloksma N; Hofhuis FM; Willers JM
Cancer Lett; 1984 Jun; 23(2):159-65. PubMed ID: 6378362
[TBL] [Abstract][Full Text] [Related]
2. Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.
Bloksma N; Hofhuis FM; Willers JM
Cancer Immunol Immunother; 1985; 19(3):205-10. PubMed ID: 3847290
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of toxic and detoxified endotoxin alone or in combination with muramyl dipeptide on lymphoid and non-lymphoid cells in the spleen of Meth A sarcoma-bearing mice.
Kuper CF; Groeneveld PH; Bloksma N
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(4):341-51. PubMed ID: 2875559
[TBL] [Abstract][Full Text] [Related]
4. Quantitative histology of muramyl dipeptide-potentiated induction of tumor necrosis by endotoxins.
Kuper CF; Bloksma N; Bruyntjes JP; Hofhuis FM
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):316-23. PubMed ID: 2889295
[TBL] [Abstract][Full Text] [Related]
5. Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.
Bloksma N; Hofhuis FM
Cancer Immunol Immunother; 1987; 24(2):165-71. PubMed ID: 3829051
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T; Ohtsuka Y; Yanagihara Y; Itoh H; Nakamoto S; Achiwa K
Int J Immunopharmacol; 1991; 13(5):605-11. PubMed ID: 1783474
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents.
Bloksma N; Hofhuis FM; Willers JM
Cancer Immunol Immunother; 1984; 17(3):154-9. PubMed ID: 6566601
[TBL] [Abstract][Full Text] [Related]
8. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide.
Nĕmecková S; Bubeník J; Jezek J; Zaoral M
Folia Biol (Praha); 1982; 28(5):327-33. PubMed ID: 7173449
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth in mice treated with synthetic muramyl dipeptide.
Bubeník J; Jezek J; Zaoral M; Hofmann J; Gruntenko YV; Osipov JG; Zolotareva AG; Vakhrusheva TE; Budker VG
Cancer Immunol Immunother; 1984; 18(2):123-5. PubMed ID: 6568871
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
[TBL] [Abstract][Full Text] [Related]
12. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. III. Eradication of disseminated murine chronic leukemia cells by utilizing MDP hapten-reactive helper T-cell activity.
Shima J; Yoshioka T; Nakajima H; Fujiwara H; Hamaoka T
Cancer Immunol Immunother; 1988; 26(1):43-7. PubMed ID: 2964268
[TBL] [Abstract][Full Text] [Related]
13. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
Dinarello CA; Elin RJ; Chedid L; Wolff SM
J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
[TBL] [Abstract][Full Text] [Related]
14. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice.
Cheadle WG; Ausobsky JR; Trachtenberg LS; Lamont P; Polk HC
Am Surg; 1986 Nov; 52(11):613-7. PubMed ID: 3535600
[TBL] [Abstract][Full Text] [Related]
15. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice.
Parant M; Parant F; Vinit MA; Jupin C; Noso Y; Chedid L
J Leukoc Biol; 1990 Feb; 47(2):164-9. PubMed ID: 2303750
[TBL] [Abstract][Full Text] [Related]
16. Some characteristics of inflammation induced by muramyl dipeptide, endotoxin, and concanavalin A.
Colditz IG; Cybulsky MI
Inflammation; 1987 Mar; 11(1):1-11. PubMed ID: 3494678
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.
Masihi KN; Brehmer W; Azuma I; Lange W; Müller S
Infect Immun; 1984 Jan; 43(1):233-7. PubMed ID: 6317568
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).
Ribi EE; Cantrell JL; Von Eschen KB; Schwartzman SM
Cancer Res; 1979 Nov; 39(11):4756-9. PubMed ID: 115579
[TBL] [Abstract][Full Text] [Related]
19. Curative properties of muramyl dipeptide in experimental Naegleria meningoencephalitis.
Ferrante A; Lederer E
Trans R Soc Trop Med Hyg; 1986; 80(2):323-6. PubMed ID: 3538525
[TBL] [Abstract][Full Text] [Related]
20. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides.
Yin JZ; Bell MK; Thorbecke GJ
J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
